Longhitano et al. reported that increased GSTK1 can mediate lactate metabolism and oxidative stress via crosstalk between GPR81/IGFBP6, thereby inhibiting breast cancer progression (Longhitano et al., 2022). Here, IGFBP6 is linked to breast carcinoma.